The pharmacokinetic profile from the therapeutic dose vary in humans needs to be decided, as scientific studies with rodents show that higher doses end in non-linear PK profile, and subjective outcomes at larger doses might depend on the CYP2D6 genotype.The preliminary therapeutic proof, along with the possible pharmacological benefits of 5?MeO?cop